200 related articles for article (PubMed ID: 2465274)
21. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
[TBL] [Abstract][Full Text] [Related]
23. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
Halperin SA; Issekutz TB; Kasina A
J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
[TBL] [Abstract][Full Text] [Related]
25. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
Boucher P; Sato H; Sato Y; Locht C
Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
[TBL] [Abstract][Full Text] [Related]
26. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
Babas T; Le Grand R; Dormont D; Bahraoui E
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
[TBL] [Abstract][Full Text] [Related]
27. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
28. Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries.
Felici F; Luzzago A; Folgori A; Cortese R
Gene; 1993 Jun; 128(1):21-7. PubMed ID: 7685299
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing epitope mapping of six beta1-bungarotoxin monoclonal antibodies and its application in beta1-bungarotoxin peptide vaccine design.
Yang CC; Chan HL
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):497-503. PubMed ID: 9461548
[TBL] [Abstract][Full Text] [Related]
30. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
[TBL] [Abstract][Full Text] [Related]
31. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies.
Peterson EM; Cheng X; Markoff BA; Fielder TJ; de la Maza LM
Infect Immun; 1991 Nov; 59(11):4147-53. PubMed ID: 1718870
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
[TBL] [Abstract][Full Text] [Related]
33. Interaction of monoclonal antibodies with pertussis toxin and its subunits.
Frank DW; Parker CD
Infect Immun; 1984 Oct; 46(1):195-201. PubMed ID: 6207108
[TBL] [Abstract][Full Text] [Related]
34. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
Schmidt MA; Schmidt W
Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
[TBL] [Abstract][Full Text] [Related]
36. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA
Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111
[TBL] [Abstract][Full Text] [Related]
37. Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant.
Cieplak W; Burnette WN; Mar VL; Kaljot KT; Morris CF; Chen KK; Sato H; Keith JM
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4667-71. PubMed ID: 2455296
[TBL] [Abstract][Full Text] [Related]
38. Determination of T cell epitopes on the S1 subunit of pertussis toxin.
Kim KJ; McKinness S; Manclark CR
J Immunol; 1990 May; 144(9):3529-34. PubMed ID: 1691761
[TBL] [Abstract][Full Text] [Related]
39. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
[TBL] [Abstract][Full Text] [Related]
40. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
